drugset / Trial / NCT03905096

A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other

NCT03905096

Phase 1 Completed 32 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of Part 1of this trial is to investigate the effect of co-administration of multiple doses of donepezil on the single-dose pharmacokinetics of BI 425809 in healthy subjects. In Part 2 the main objective is the investigation of the effect of co-administration of multiple doses of BI 425809 on the single-dose pharmacokinetics of donepezil in healthy subjects.

Timeline

Start
2019-04-12
Primary completion
2019-08-30
Completion
2019-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule
Subject Iclepertin Small molecule

Indications

No indication recorded.